Interesting approach using monoclonal antibodies to treat Covid-19 infections. However clinical trials must follow to confirm in vitro findings. May 8, 2020May 8, 2020Dr. Barry Dworkin Medical Mythbusting Commentary for May 8, 2020 Interesting approach using monoclonal antibodies to treat Covid-19 infections. However clinical trials must follow to confirm in vitro findings. Play Now | Play in Popup | Download Source:Israel’s IIBR finds antibody that neutralizes coronavirus Related posts: New class of prostate cancer drug treatment to start clinical trials Remdesivir may help treat Covid-19 but the predictable media hype misrepresents the science. The data has not been published nor peer reviewed. There is a study in the Lancet that does not demonstrate efficacy hence the need for further investigation to determine if this truly is a treatment option. Sunday House Call, #728, March 1, 2020: The approach to Covid-19 when it finally comes is to remember the sage advice of Kipling’s If. Cranberries in all forms do not prevent or treat urinary tract infections Covid-19monoclonal antibodies